Publication: Serum fetuin-A levels in patients with systolic heart failure
dc.contributor.buuauthor | Keçebaş, Mesut | |
dc.contributor.buuauthor | Güllülü, Sümeyye | |
dc.contributor.buuauthor | Saǧ, Saim | |
dc.contributor.buuauthor | Beşli, Feyzullah | |
dc.contributor.buuauthor | Açıkgöz, Ebru | |
dc.contributor.buuauthor | Sarandöl, Emre | |
dc.contributor.buuauthor | Aydınlar, Ali Altun | |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Kardiyoloji Anabilim Dalı. | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Biyokimya Anabilim Dalı. | tr_TR |
dc.contributor.orcid | 0000-0002-2593-7196 | tr_TR |
dc.contributor.orcid | 0000-0001-8404-8252 | tr_TR |
dc.contributor.orcid | 0000-0002-8974-8837 | tr_TR |
dc.contributor.researcherid | ABE-1716-2020 | tr_TR |
dc.contributor.researcherid | AAW-9185-2020 | tr_TR |
dc.contributor.researcherid | AAI-6632-2021 | tr_TR |
dc.contributor.scopusid | 36198369900 | tr_TR |
dc.contributor.scopusid | 57204660708 | tr_TR |
dc.contributor.scopusid | 12140008100 | tr_TR |
dc.contributor.scopusid | 35767335000 | tr_TR |
dc.contributor.scopusid | 56328183700 | tr_TR |
dc.contributor.scopusid | 55943324800 | tr_TR |
dc.contributor.scopusid | 6603131517 | tr_TR |
dc.date.accessioned | 2024-02-26T11:04:44Z | |
dc.date.available | 2024-02-26T11:04:44Z | |
dc.date.issued | 2014-05-05 | |
dc.description.abstract | Objective Inflammation and dystrophic calcification have been associated with cardiovascular disease (CVD) and chronic heart failure (CHF). The aim of the present study was to investigate the potential usefulness of fetuin-A as a biomarker in CHF. Methods Serum fetuin-A was measured in 66 CHF patients with left ventricular function < 50% and in 31 healthy controls at baseline. Fetuin-A was evaluated as a diagnostic marker for systolic heart failure and compared with C-reactive protein (CRP) and pro-brain natriuretic peptide (pro-BNP). Results The levels of serum fetuin-A were significantly decreased in the CHF patients compared to the control group (P < 0.01). Although there were significant correlations between fetuin-A and certain parameters in patients and controls, none of these were present consistently in either group. It was found that serum fetuin-A levels could identify patients with systolic heart failure with a high degree of sensitivity and specificity. Conclusions Serum fetuin-A is decreased in CHF patients, indicating that anti-inflammatory activity is downregulated in CHF and that calcification may be associated with CHF. | en_US |
dc.identifier.citation | Keçebaş, M. vd. (2014). "Serum fetuin-A levels in patients with systolic heart failure". Acta Cardiologica, 69(4), 399-405. | en_US |
dc.identifier.doi | https://doi.org/10.2143/AC.69.4.3036656 | en_US |
dc.identifier.eissn | 1784-973X | |
dc.identifier.endpage | 405 | tr_TR |
dc.identifier.issn | 0001-5385 | |
dc.identifier.issue | 4 | tr_TR |
dc.identifier.pubmed | 25181915 | tr_TR |
dc.identifier.scopus | 2-s2.0-84906089008 | tr_TR |
dc.identifier.startpage | 399 | tr_TR |
dc.identifier.uri | https://www.tandfonline.com/doi/abs/10.1080/AC.69.4.3036656 | en_US |
dc.identifier.uri | https://hdl.handle.net/11452/39966 | en_US |
dc.identifier.volume | 69 | tr_TR |
dc.identifier.wos | 000346681400007 | |
dc.indexed.wos | SCIE | en_US |
dc.language.iso | en | en_US |
dc.publisher | Taylor & Francis Ltd | en_US |
dc.relation.journal | Acta Cardiologica | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Chronic heart failure | en_US |
dc.subject | Inflammation | en_US |
dc.subject | Fetuin-A | en_US |
dc.subject | Alpha(2)-heremans-schmid glycoprotein/fetuin-a | en_US |
dc.subject | Diastolic dysfunction | en_US |
dc.subject | Mechanisms | en_US |
dc.subject | Insulin-resistance | en_US |
dc.subject | Accumulation | en_US |
dc.subject | Hs-glycoprotein | en_US |
dc.subject | Expression | en_US |
dc.subject | Calcification | en_US |
dc.subject | Association | en_US |
dc.subject | Cardiovascular system & cardiology | en_US |
dc.subject.emtree | Adult | en_US |
dc.subject.emtree | Aged | en_US |
dc.subject.emtree | Antiinflammatory activity | en_US |
dc.subject.emtree | Article | en_US |
dc.subject.emtree | Blood examination | en_US |
dc.subject.emtree | Blood pressure | en_US |
dc.subject.emtree | Cardiomyopathy | en_US |
dc.subject.emtree | Cardiovascular parameters | en_US |
dc.subject.emtree | Congestive heart failure | en_US |
dc.subject.emtree | Controlled study | en_US |
dc.subject.emtree | Creatinine blood level | en_US |
dc.subject.emtree | Diagnostic test accuracy study | en_US |
dc.subject.emtree | Disease marker | en_US |
dc.subject.emtree | Disease severity | en_US |
dc.subject.emtree | Echocardiography | en_US |
dc.subject.emtree | End diastolic diameter | en_US |
dc.subject.emtree | End systolic diameter | en_US |
dc.subject.emtree | Enzyme linked immunosorbent assay | en_US |
dc.subject.emtree | Female | en_US |
dc.subject.emtree | Glomerulus filtration rate | en_US |
dc.subject.emtree | Heart left ventricle ejection fraction | en_US |
dc.subject.emtree | Heart left ventricle function | en_US |
dc.subject.emtree | Human | en_US |
dc.subject.emtree | Ischemic heart disease | en_US |
dc.subject.emtree | Kidney disease | en_US |
dc.subject.emtree | Major clinical study | en_US |
dc.subject.emtree | Male | en_US |
dc.subject.emtree | New york heart association class | en_US |
dc.subject.emtree | Receiver operating characteristic | en_US |
dc.subject.emtree | Sensitivity and specificity | en_US |
dc.subject.emtree | Systolic heart failure | en_US |
dc.subject.emtree | Thorax radiography | en_US |
dc.subject.emtree | Acetylsalicylic acid | en_US |
dc.subject.emtree | Angiotensin 2 receptor antagonist | en_US |
dc.subject.emtree | Brain natriuretic peptide | en_US |
dc.subject.emtree | C reactive protein | en_US |
dc.subject.emtree | Calcium channel blocking agent | en_US |
dc.subject.emtree | Digitoxin | en_US |
dc.subject.emtree | Dipeptidyl carboxypeptidase inhibitor | en_US |
dc.subject.emtree | Fetuin a | en_US |
dc.subject.emtree | Furosemide | en_US |
dc.subject.emtree | Hemoglobin | en_US |
dc.subject.emtree | High density lipoprotein | en_US |
dc.subject.emtree | Hydroxymethylglutaryl coenzyme a reductase inhibitor | en_US |
dc.subject.emtree | Low density lipoprotein | en_US |
dc.subject.emtree | Nitric acid derivative | en_US |
dc.subject.emtree | Spironolactone | en_US |
dc.subject.emtree | Triacylglycerol | en_US |
dc.subject.mesh | Aged | en_US |
dc.subject.mesh | Alpha-2-hs-glycoprotein | en_US |
dc.subject.mesh | Biological markers | en_US |
dc.subject.mesh | C-reactive protein | en_US |
dc.subject.mesh | Case-control studies | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Heart failure, systolic | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Middle aged | en_US |
dc.subject.mesh | Natriuretic peptide, brain | en_US |
dc.subject.mesh | Peptide fragments | en_US |
dc.subject.mesh | Predictive value of tests | en_US |
dc.subject.mesh | Sensitivity and specificity | en_US |
dc.subject.mesh | Severity of illness index | en_US |
dc.subject.mesh | Ventricular dysfunction, left | en_US |
dc.subject.scopus | Fetuin A; Glycoprotein; Human AHSG Protein | en_US |
dc.subject.wos | Cardiac & cardiovascular systems | en_US |
dc.title | Serum fetuin-A levels in patients with systolic heart failure | en_US |
dc.type | Article | en_US |
dc.wos.quartile | Q4 (Cardiac & Cardiovascular Systems) | en_US |
dspace.entity.type | Publication |
Files
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: